Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vascular Malformations | 17 | 2022 | 471 | 2.490 |
Why?
|
Lymphatic Abnormalities | 7 | 2019 | 134 | 2.280 |
Why?
|
Hemangioendothelioma | 6 | 2018 | 112 | 1.530 |
Why?
|
Sarcoma, Kaposi | 5 | 2016 | 375 | 1.240 |
Why?
|
Thrombosis | 13 | 2018 | 2949 | 1.240 |
Why?
|
Sirolimus | 7 | 2021 | 1545 | 0.940 |
Why?
|
Thrombophilia | 5 | 2013 | 308 | 0.820 |
Why?
|
Esophageal Atresia | 2 | 2016 | 225 | 0.780 |
Why?
|
Angiomatosis | 2 | 2017 | 45 | 0.670 |
Why?
|
Osteolysis, Essential | 2 | 2018 | 30 | 0.610 |
Why?
|
Thromboembolism | 2 | 2014 | 1003 | 0.560 |
Why?
|
Neck | 2 | 2021 | 733 | 0.540 |
Why?
|
Colitis | 2 | 2014 | 1239 | 0.480 |
Why?
|
Upper Extremity Deep Vein Thrombosis | 1 | 2015 | 25 | 0.480 |
Why?
|
Perinatal Care | 1 | 2017 | 246 | 0.470 |
Why?
|
Skin Diseases | 3 | 2021 | 1088 | 0.470 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2015 | 103 | 0.450 |
Why?
|
Heparin | 3 | 2018 | 1630 | 0.450 |
Why?
|
Venous Thromboembolism | 3 | 2020 | 1882 | 0.450 |
Why?
|
Inflammatory Bowel Diseases | 3 | 2014 | 2429 | 0.450 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2017 | 245 | 0.410 |
Why?
|
Immunosuppressive Agents | 4 | 2021 | 4209 | 0.410 |
Why?
|
Anticoagulants | 5 | 2018 | 4862 | 0.410 |
Why?
|
Infant | 28 | 2023 | 36386 | 0.410 |
Why?
|
Vincristine | 1 | 2015 | 1039 | 0.410 |
Why?
|
Pulmonary Embolism | 3 | 2018 | 2598 | 0.400 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2014 | 207 | 0.390 |
Why?
|
Infant, Newborn, Diseases | 1 | 2017 | 587 | 0.380 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2015 | 616 | 0.370 |
Why?
|
Face | 1 | 2017 | 1028 | 0.370 |
Why?
|
Steroids | 1 | 2015 | 933 | 0.340 |
Why?
|
Thrombocytopenia | 2 | 2014 | 1171 | 0.330 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2011 | 187 | 0.330 |
Why?
|
Blood Coagulation | 5 | 2018 | 1166 | 0.320 |
Why?
|
Catheterization, Central Venous | 1 | 2014 | 539 | 0.310 |
Why?
|
Stroke | 5 | 2023 | 9747 | 0.300 |
Why?
|
Child, Preschool | 24 | 2021 | 42500 | 0.290 |
Why?
|
Child | 30 | 2023 | 80564 | 0.290 |
Why?
|
Fibrinolytic Agents | 2 | 2014 | 2080 | 0.280 |
Why?
|
Cranial Sinuses | 2 | 2017 | 68 | 0.280 |
Why?
|
Musculoskeletal Abnormalities | 2 | 2018 | 101 | 0.270 |
Why?
|
Hemorrhage | 3 | 2018 | 3461 | 0.270 |
Why?
|
Klippel-Trenaunay-Weber Syndrome | 2 | 2018 | 68 | 0.260 |
Why?
|
Nevus | 2 | 2018 | 205 | 0.250 |
Why?
|
Lipoma | 2 | 2018 | 294 | 0.250 |
Why?
|
Interdisciplinary Communication | 1 | 2011 | 932 | 0.240 |
Why?
|
Lipoproteins | 1 | 2009 | 866 | 0.240 |
Why?
|
Infant, Newborn | 15 | 2021 | 26346 | 0.230 |
Why?
|
Intracranial Arteriovenous Malformations | 2 | 2017 | 360 | 0.230 |
Why?
|
Patient Care Team | 1 | 2015 | 2517 | 0.220 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 7425 | 0.220 |
Why?
|
Adolescent | 24 | 2021 | 88835 | 0.210 |
Why?
|
Lymph Nodes | 1 | 2013 | 3454 | 0.200 |
Why?
|
Cardiac Surgical Procedures | 5 | 2018 | 3675 | 0.200 |
Why?
|
Retrospective Studies | 21 | 2023 | 81514 | 0.190 |
Why?
|
Gene Deletion | 1 | 2009 | 2666 | 0.190 |
Why?
|
Male | 44 | 2021 | 363698 | 0.190 |
Why?
|
Veins | 2 | 2018 | 764 | 0.190 |
Why?
|
Humans | 66 | 2023 | 765968 | 0.180 |
Why?
|
Quality Improvement | 1 | 2016 | 3853 | 0.180 |
Why?
|
Hematology | 2 | 2017 | 243 | 0.180 |
Why?
|
Partial Thromboplastin Time | 2 | 2018 | 202 | 0.180 |
Why?
|
Female | 42 | 2023 | 396112 | 0.170 |
Why?
|
Transferrin | 2 | 2005 | 283 | 0.170 |
Why?
|
Factor Xa | 2 | 2018 | 166 | 0.170 |
Why?
|
Risk Factors | 15 | 2020 | 74840 | 0.170 |
Why?
|
Heart Defects, Congenital | 4 | 2018 | 4697 | 0.170 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2015 | 5337 | 0.170 |
Why?
|
Venous Thrombosis | 1 | 2009 | 1327 | 0.170 |
Why?
|
Thalidomide | 2 | 2016 | 886 | 0.160 |
Why?
|
Boston | 7 | 2022 | 9338 | 0.160 |
Why?
|
Sclerotherapy | 3 | 2019 | 184 | 0.160 |
Why?
|
Antibodies, Anticardiolipin | 3 | 2013 | 62 | 0.160 |
Why?
|
Ultrasonography, Prenatal | 2 | 2017 | 1774 | 0.160 |
Why?
|
Angiofibroma | 1 | 2019 | 57 | 0.150 |
Why?
|
Neoplasm Staging | 1 | 2013 | 11206 | 0.150 |
Why?
|
Hemangioendothelioma, Epithelioid | 1 | 2019 | 52 | 0.150 |
Why?
|
Protein-Losing Enteropathies | 1 | 2018 | 45 | 0.150 |
Why?
|
Young Adult | 16 | 2021 | 59889 | 0.150 |
Why?
|
Postoperative Complications | 4 | 2017 | 15747 | 0.150 |
Why?
|
Thoracic Duct | 1 | 2018 | 71 | 0.150 |
Why?
|
Chylothorax | 1 | 2018 | 83 | 0.140 |
Why?
|
Mucous Membrane | 1 | 2021 | 657 | 0.140 |
Why?
|
Soft Tissue Neoplasms | 2 | 2019 | 1165 | 0.140 |
Why?
|
Physician-Patient Relations | 1 | 2010 | 3278 | 0.140 |
Why?
|
Cation Transport Proteins | 4 | 2001 | 325 | 0.140 |
Why?
|
Lower Extremity | 3 | 2020 | 1226 | 0.140 |
Why?
|
Varicose Veins | 1 | 2018 | 158 | 0.130 |
Why?
|
Angiopoietins | 1 | 2016 | 86 | 0.130 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2019 | 296 | 0.130 |
Why?
|
Upper Extremity | 2 | 2019 | 682 | 0.130 |
Why?
|
Central Nervous System Vascular Malformations | 1 | 2017 | 142 | 0.130 |
Why?
|
Endothelial Cells | 2 | 2022 | 3584 | 0.120 |
Why?
|
Muscular Diseases | 1 | 2020 | 550 | 0.120 |
Why?
|
Placenta Diseases | 1 | 2018 | 199 | 0.120 |
Why?
|
Platelet Function Tests | 1 | 2017 | 275 | 0.120 |
Why?
|
Cerebral Palsy | 1 | 2020 | 481 | 0.120 |
Why?
|
Lymphatic System | 1 | 2016 | 250 | 0.120 |
Why?
|
Drug Monitoring | 2 | 2018 | 962 | 0.120 |
Why?
|
Wnt Proteins | 1 | 2019 | 722 | 0.120 |
Why?
|
Health Resources | 1 | 2021 | 949 | 0.120 |
Why?
|
Incidence | 5 | 2020 | 21480 | 0.120 |
Why?
|
Head | 1 | 2021 | 925 | 0.120 |
Why?
|
Anastomosis, Surgical | 1 | 2018 | 990 | 0.120 |
Why?
|
Propranolol | 1 | 2016 | 492 | 0.120 |
Why?
|
Algorithms | 1 | 2015 | 14071 | 0.110 |
Why?
|
Wilms Tumor | 1 | 2017 | 379 | 0.110 |
Why?
|
Arteriovenous Fistula | 1 | 2017 | 311 | 0.110 |
Why?
|
Factor VIII | 2 | 2013 | 347 | 0.110 |
Why?
|
Postoperative Hemorrhage | 1 | 2018 | 413 | 0.110 |
Why?
|
Vascular Diseases | 1 | 2022 | 1159 | 0.110 |
Why?
|
Diagnostic Imaging | 2 | 2019 | 3529 | 0.110 |
Why?
|
von Willebrand Factor | 1 | 2017 | 676 | 0.110 |
Why?
|
Thoracic Vertebrae | 1 | 2018 | 614 | 0.110 |
Why?
|
Diphosphonates | 1 | 2018 | 625 | 0.110 |
Why?
|
Hemangioma | 1 | 2018 | 723 | 0.110 |
Why?
|
Muscle, Skeletal | 3 | 2020 | 4958 | 0.110 |
Why?
|
Tracheostomy | 1 | 2017 | 429 | 0.110 |
Why?
|
Hemoglobinuria | 1 | 2012 | 12 | 0.100 |
Why?
|
Liver Neoplasms | 2 | 2019 | 4353 | 0.100 |
Why?
|
Oliguria | 1 | 2012 | 20 | 0.100 |
Why?
|
Interferons | 1 | 2016 | 714 | 0.100 |
Why?
|
Blood Coagulation Tests | 1 | 2013 | 263 | 0.100 |
Why?
|
Combined Modality Therapy | 2 | 2015 | 8529 | 0.100 |
Why?
|
Lung | 3 | 2022 | 10033 | 0.100 |
Why?
|
Spinal Cord | 1 | 2020 | 1784 | 0.100 |
Why?
|
Diagnosis, Differential | 3 | 2017 | 12976 | 0.100 |
Why?
|
Ventricular Function | 1 | 2013 | 403 | 0.090 |
Why?
|
Progesterone Congeners | 1 | 2011 | 42 | 0.090 |
Why?
|
Scoliosis | 1 | 2018 | 789 | 0.090 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 2012 | 116 | 0.090 |
Why?
|
Catheters, Indwelling | 1 | 2013 | 438 | 0.090 |
Why?
|
Contraceptives, Oral | 1 | 2013 | 559 | 0.090 |
Why?
|
Peripheral Vascular Diseases | 1 | 2014 | 516 | 0.090 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2016 | 1237 | 0.090 |
Why?
|
Prognosis | 5 | 2019 | 29922 | 0.090 |
Why?
|
Adenosine Triphosphatases | 1 | 1994 | 837 | 0.090 |
Why?
|
Metals | 1 | 1994 | 710 | 0.090 |
Why?
|
Orthopedic Procedures | 1 | 2020 | 1280 | 0.090 |
Why?
|
Diagnostic Errors | 1 | 2017 | 1275 | 0.080 |
Why?
|
Consensus | 1 | 2019 | 3202 | 0.080 |
Why?
|
Cell-Derived Microparticles | 1 | 2011 | 160 | 0.080 |
Why?
|
Alleles | 1 | 2000 | 6897 | 0.080 |
Why?
|
Treatment Outcome | 9 | 2020 | 65188 | 0.080 |
Why?
|
Thromboplastin | 1 | 2011 | 289 | 0.080 |
Why?
|
Medical Oncology | 2 | 2018 | 2339 | 0.080 |
Why?
|
Adult | 15 | 2021 | 223044 | 0.080 |
Why?
|
Placenta | 1 | 2018 | 1728 | 0.080 |
Why?
|
Recurrence | 2 | 2020 | 8501 | 0.080 |
Why?
|
Hospitals, Pediatric | 1 | 2017 | 1846 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2019 | 3513 | 0.070 |
Why?
|
Catheterization | 1 | 2013 | 1425 | 0.070 |
Why?
|
Iron-Binding Proteins | 2 | 1998 | 83 | 0.070 |
Why?
|
Mutation | 5 | 2017 | 30198 | 0.070 |
Why?
|
Abnormalities, Multiple | 1 | 2015 | 1424 | 0.070 |
Why?
|
Body Weight | 2 | 2017 | 4622 | 0.070 |
Why?
|
Membrane Proteins | 5 | 2005 | 7851 | 0.070 |
Why?
|
Bone Neoplasms | 1 | 2019 | 2567 | 0.070 |
Why?
|
Disease Management | 1 | 2017 | 2535 | 0.070 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2012 | 788 | 0.070 |
Why?
|
Awareness | 1 | 2011 | 653 | 0.070 |
Why?
|
Angiogenesis Inhibitors | 1 | 2016 | 2056 | 0.070 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6309 | 0.070 |
Why?
|
Genetic Testing | 1 | 2019 | 3595 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3807 | 0.060 |
Why?
|
Aspirin | 1 | 2017 | 3134 | 0.060 |
Why?
|
Amino Acid Substitution | 2 | 2001 | 1740 | 0.060 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2015 | 2878 | 0.060 |
Why?
|
Colon | 1 | 2013 | 1795 | 0.060 |
Why?
|
Pain | 1 | 2020 | 5077 | 0.060 |
Why?
|
Cohort Studies | 3 | 2017 | 41649 | 0.060 |
Why?
|
Sciatic Nerve | 2 | 1999 | 628 | 0.060 |
Why?
|
Pregnancy | 4 | 2023 | 30260 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 15398 | 0.060 |
Why?
|
Ultrasonography | 1 | 2017 | 5993 | 0.060 |
Why?
|
Bacteria | 1 | 1994 | 2209 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 14652 | 0.050 |
Why?
|
Disease Progression | 2 | 2017 | 13632 | 0.050 |
Why?
|
Age Factors | 3 | 2018 | 18380 | 0.050 |
Why?
|
Anemia | 2 | 2005 | 1511 | 0.050 |
Why?
|
Clinical Protocols | 2 | 2018 | 1441 | 0.050 |
Why?
|
Diabetes Mellitus, Experimental | 2 | 1999 | 1118 | 0.050 |
Why?
|
Carrier Proteins | 3 | 2001 | 4913 | 0.050 |
Why?
|
Brain | 2 | 2020 | 27171 | 0.050 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2017 | 904 | 0.050 |
Why?
|
Mononuclear Phagocyte System | 1 | 2001 | 55 | 0.050 |
Why?
|
Running | 1 | 2006 | 488 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 8041 | 0.050 |
Why?
|
GTP-Binding Proteins | 1 | 2005 | 945 | 0.050 |
Why?
|
DNA | 1 | 2015 | 7202 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2017 | 39193 | 0.050 |
Why?
|
Glutathione Peroxidase | 2 | 1999 | 256 | 0.040 |
Why?
|
Administration, Oral | 2 | 2021 | 4015 | 0.040 |
Why?
|
Kidney Neoplasms | 1 | 2017 | 4274 | 0.040 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2001 | 313 | 0.040 |
Why?
|
Patient Education as Topic | 1 | 2010 | 2334 | 0.040 |
Why?
|
Risk Assessment | 4 | 2018 | 24282 | 0.040 |
Why?
|
Hemochromatosis | 1 | 2001 | 175 | 0.040 |
Why?
|
Vascular Surgical Procedures | 2 | 2018 | 1485 | 0.040 |
Why?
|
Hemoglobins | 1 | 2005 | 1530 | 0.040 |
Why?
|
Survival Rate | 1 | 2013 | 12795 | 0.040 |
Why?
|
Referral and Consultation | 1 | 2012 | 3615 | 0.040 |
Why?
|
Iron | 4 | 2005 | 1816 | 0.040 |
Why?
|
United States | 3 | 2018 | 72903 | 0.040 |
Why?
|
Time Factors | 6 | 2018 | 40065 | 0.040 |
Why?
|
Magnetic Resonance Angiography | 2 | 2017 | 1426 | 0.040 |
Why?
|
Genes, Dominant | 1 | 2001 | 856 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 5 | 2019 | 36532 | 0.040 |
Why?
|
Quality of Life | 2 | 2017 | 13462 | 0.040 |
Why?
|
Dissection | 1 | 2020 | 299 | 0.040 |
Why?
|
Sequence Homology, Amino Acid | 3 | 2001 | 2745 | 0.040 |
Why?
|
Lymphography | 1 | 2018 | 189 | 0.040 |
Why?
|
Pediatrics | 2 | 2018 | 3606 | 0.040 |
Why?
|
Prevalence | 1 | 2014 | 15842 | 0.040 |
Why?
|
Prospective Studies | 5 | 2023 | 54802 | 0.040 |
Why?
|
Protein Kinase C | 2 | 1999 | 1202 | 0.030 |
Why?
|
Phlebography | 1 | 2018 | 328 | 0.030 |
Why?
|
Cloning, Molecular | 3 | 2001 | 4165 | 0.030 |
Why?
|
Chorioamnionitis | 1 | 2018 | 155 | 0.030 |
Why?
|
Dilatation, Pathologic | 1 | 2018 | 527 | 0.030 |
Why?
|
Smoking | 1 | 2013 | 9081 | 0.030 |
Why?
|
Ultrasonography, Doppler | 1 | 2018 | 460 | 0.030 |
Why?
|
Perioperative Period | 1 | 2017 | 251 | 0.030 |
Why?
|
DNA, Complementary | 2 | 2001 | 1984 | 0.030 |
Why?
|
Perfusion Imaging | 1 | 2017 | 193 | 0.030 |
Why?
|
Menkes Kinky Hair Syndrome | 1 | 1994 | 18 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1998 | 1679 | 0.030 |
Why?
|
Biopsy | 2 | 2019 | 6763 | 0.030 |
Why?
|
Glycine | 1 | 1998 | 672 | 0.030 |
Why?
|
Chemoprevention | 1 | 2017 | 327 | 0.030 |
Why?
|
Arginine | 1 | 1998 | 933 | 0.030 |
Why?
|
Mice, Mutant Strains | 3 | 2005 | 1745 | 0.030 |
Why?
|
Middle Aged | 7 | 2021 | 223009 | 0.030 |
Why?
|
Hepatolenticular Degeneration | 1 | 1994 | 73 | 0.030 |
Why?
|
Lymphatic Vessels | 1 | 2018 | 355 | 0.030 |
Why?
|
Bronchoalveolar Lavage | 1 | 2014 | 131 | 0.030 |
Why?
|
Plasminogen Inactivators | 1 | 2013 | 37 | 0.030 |
Why?
|
Histidine | 1 | 1994 | 301 | 0.030 |
Why?
|
Platelet Aggregation | 1 | 2017 | 769 | 0.030 |
Why?
|
Diabetic Neuropathies | 1 | 1998 | 408 | 0.030 |
Why?
|
DNA Probes | 1 | 1994 | 541 | 0.030 |
Why?
|
Molecular Sequence Data | 4 | 2005 | 17594 | 0.030 |
Why?
|
Protein S | 1 | 2012 | 29 | 0.030 |
Why?
|
beta 2-Glycoprotein I | 1 | 2012 | 27 | 0.030 |
Why?
|
Spine | 1 | 2020 | 1128 | 0.030 |
Why?
|
Sodium Tetradecyl Sulfate | 1 | 2012 | 14 | 0.030 |
Why?
|
Antithrombin III | 1 | 2012 | 128 | 0.030 |
Why?
|
Protein C | 1 | 2012 | 134 | 0.020 |
Why?
|
Animals | 10 | 2011 | 168764 | 0.020 |
Why?
|
Sclerosing Solutions | 1 | 2012 | 80 | 0.020 |
Why?
|
Automation, Laboratory | 1 | 2012 | 102 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2001 | 2589 | 0.020 |
Why?
|
Receptors, Transferrin | 2 | 2005 | 300 | 0.020 |
Why?
|
Gene Library | 1 | 1994 | 1067 | 0.020 |
Why?
|
Ischemic Attack, Transient | 1 | 2017 | 870 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2013 | 18071 | 0.020 |
Why?
|
Cell Membrane | 1 | 2001 | 3634 | 0.020 |
Why?
|
Blood Coagulation Factors | 1 | 2013 | 371 | 0.020 |
Why?
|
Thrombin | 1 | 2013 | 602 | 0.020 |
Why?
|
Amino Acid Sequence | 3 | 2001 | 13400 | 0.020 |
Why?
|
Biomedical Research | 1 | 2006 | 3458 | 0.020 |
Why?
|
Bone and Bones | 1 | 2001 | 2554 | 0.020 |
Why?
|
Species Specificity | 1 | 1994 | 2406 | 0.020 |
Why?
|
Cough | 1 | 2014 | 597 | 0.020 |
Why?
|
Calibration | 1 | 2012 | 814 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4850 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2018 | 3537 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2018 | 22223 | 0.020 |
Why?
|
Reoperation | 1 | 2020 | 4294 | 0.020 |
Why?
|
Perioperative Care | 1 | 2017 | 1055 | 0.020 |
Why?
|
Arteriovenous Malformations | 1 | 2012 | 397 | 0.020 |
Why?
|
Developing Countries | 1 | 2021 | 2911 | 0.020 |
Why?
|
Streptococcus pneumoniae | 1 | 2014 | 762 | 0.020 |
Why?
|
Spinal Fusion | 1 | 2018 | 1302 | 0.020 |
Why?
|
Mice | 8 | 2005 | 81819 | 0.020 |
Why?
|
Mitochondria | 1 | 2001 | 3673 | 0.020 |
Why?
|
Naphthalenes | 2 | 1999 | 197 | 0.020 |
Why?
|
Blood Glucose | 2 | 1999 | 6424 | 0.020 |
Why?
|
Cerebrovascular Circulation | 1 | 2017 | 2674 | 0.020 |
Why?
|
Fever | 1 | 2014 | 1603 | 0.020 |
Why?
|
Particle Size | 1 | 2011 | 1631 | 0.020 |
Why?
|
Oxidative Stress | 1 | 1998 | 3141 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2012 | 1119 | 0.020 |
Why?
|
Ethanol | 1 | 2012 | 1323 | 0.020 |
Why?
|
Genetic Markers | 1 | 2012 | 2601 | 0.020 |
Why?
|
Internship and Residency | 1 | 2006 | 5946 | 0.020 |
Why?
|
ROC Curve | 1 | 2013 | 3620 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2015 | 6069 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2017 | 2770 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10729 | 0.020 |
Why?
|
Genetic Complementation Test | 1 | 2005 | 557 | 0.010 |
Why?
|
Endovascular Procedures | 1 | 2018 | 2222 | 0.010 |
Why?
|
rab GTP-Binding Proteins | 1 | 2005 | 245 | 0.010 |
Why?
|
Base Sequence | 1 | 1994 | 12403 | 0.010 |
Why?
|
Biological Transport | 2 | 1998 | 2081 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12056 | 0.010 |
Why?
|
Retroviridae | 1 | 2005 | 847 | 0.010 |
Why?
|
Mutagenesis, Insertional | 1 | 2005 | 661 | 0.010 |
Why?
|
Radiography | 1 | 2014 | 6919 | 0.010 |
Why?
|
Mass Screening | 1 | 2018 | 5446 | 0.010 |
Why?
|
Endosomes | 1 | 2005 | 523 | 0.010 |
Why?
|
Escherichia coli | 1 | 1994 | 4214 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3655 | 0.010 |
Why?
|
Registries | 1 | 2018 | 8297 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2014 | 3312 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9649 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2005 | 1495 | 0.010 |
Why?
|
Lod Score | 1 | 2001 | 598 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2012 | 4528 | 0.010 |
Why?
|
Physical Chromosome Mapping | 1 | 2001 | 183 | 0.010 |
Why?
|
Codon | 1 | 2001 | 595 | 0.010 |
Why?
|
Italy | 1 | 2001 | 854 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2001 | 1546 | 0.010 |
Why?
|
Iron Overload | 1 | 2001 | 245 | 0.010 |
Why?
|
Frameshift Mutation | 1 | 2001 | 393 | 0.010 |
Why?
|
Mice, Inbred C57BL | 3 | 2005 | 22332 | 0.010 |
Why?
|
Genetic Heterogeneity | 1 | 2001 | 735 | 0.010 |
Why?
|
Enzyme Inhibitors | 2 | 1999 | 3715 | 0.010 |
Why?
|
Open Reading Frames | 1 | 2001 | 820 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2005 | 2729 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2001 | 2266 | 0.010 |
Why?
|
Mice, Inbred DBA | 1 | 1997 | 623 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 1997 | 914 | 0.010 |
Why?
|
HLA Antigens | 1 | 2001 | 1339 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15880 | 0.010 |
Why?
|
Cytosol | 1 | 1999 | 885 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 1998 | 1210 | 0.010 |
Why?
|
Aged | 2 | 2019 | 171117 | 0.010 |
Why?
|
Exons | 1 | 2001 | 2391 | 0.010 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 1998 | 479 | 0.010 |
Why?
|
Microsatellite Repeats | 1 | 1997 | 784 | 0.010 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2001 | 1365 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2012 | 20124 | 0.010 |
Why?
|
Pedigree | 1 | 2001 | 4526 | 0.010 |
Why?
|
Blotting, Western | 1 | 2001 | 5020 | 0.010 |
Why?
|
Phenotype | 2 | 2001 | 16721 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2001 | 4108 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2001 | 6220 | 0.010 |
Why?
|
Haplotypes | 1 | 1997 | 2728 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20659 | 0.010 |
Why?
|
Models, Genetic | 1 | 2001 | 3449 | 0.010 |
Why?
|
Heterozygote | 1 | 1997 | 2794 | 0.010 |
Why?
|
Homeostasis | 1 | 2001 | 3336 | 0.010 |
Why?
|
Cell Line | 1 | 2001 | 15543 | 0.000 |
Why?
|
Kidney | 1 | 1998 | 7066 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1998 | 18973 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 1997 | 18293 | 0.000 |
Why?
|